Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 333241 - 333260 out of 566181 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Italy | (L01EM01) idelalisib (adm: O) | ZYDELIG*60 cpr rivestite 150 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Leukemia, Lymphocytic, Chronic, B-Cell | GILEADSCIENCESIRELANDUC |
| Italy | (L01EM03) alpelisib (adm: O) | PIQRAY*56 cpr rivestite 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EM03) alpelisib (adm: O) | PIQRAY*28 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EM03) alpelisib (adm: O) | PIQRAY*28 cpr rivestite 50 mg + 28 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NOVARTISEUROPHARMLTD |
| Italy | (L01EN04) futibatinib | LYTGOBI*21 cpr rivestite 4 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TAIHOPHARMANETHERLANDSBV |
| Italy | (L01EN04) futibatinib | LYTGOBI*28 cpr rivestite 4 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TAIHOPHARMANETHERLANDSBV |
| Italy | (L01EN04) futibatinib | LYTGOBI*35 cpr rivestite 4 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | TAIHOPHARMANETHERLANDSBV |
| Italy | (L01EP01) capmatinib (adm: O) | TABRECTA*120 cpr rivestite 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NOVARTISEUROPHARMLTD |
| Italy | (L01EP01) capmatinib (adm: O) | TABRECTA*120 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NOVARTISEUROPHARMLTD |
| Italy | (L01EX02) sorafenib (adm: O) | NEXAVAR*112 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BAYERAG |
| Italy | (L01EX02) sorafenib (adm: O) | SORAFENIB*112 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAITALIASrl |
| Italy | (L01EX02) sorafenib (adm: O) | SORAFENIB*112 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACPHARMASrl |
| Italy | (L01EX02) sorafenib (adm: O) | SORAFENIB*112 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MYLANSpA |
| Italy | (L01EX02) sorafenib (adm: O) | SORAFENIB*112x1 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ZENTIVAITALIASrl |
| Italy | (L01EX02) sorafenib (adm: O) | SORAFENIB*112x1 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | EGSpA |
| Italy | (L01EX03) pazopanib (adm: O) | PAZOPANIB*30 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCARESLU |
| Italy | (L01EX03) pazopanib (adm: O) | PAZOPANIB*30 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MYLANSpA |
| Italy | (L01EX03) pazopanib (adm: O) | PAZOPANIB*30 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAITALIASrl |
| Italy | (L01EX03) pazopanib (adm: O) | PAZOPANIB*30 cpr rivestite 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | DR.REDDYSSrl |
| Italy | (L01EX03) pazopanib (adm: O) | PAZOPANIB*30 cpr rivestite 400 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | ACCORDHEALTHCARESLU |
Pages
